10/08/2026
"It made a mistake, so we can't trust it." Sound familiar?
Dilbir Bain, CEO of Galaxy Pharmaceuticals, has heard it too, and in a business that makes sterile injectable medications under FDA oversight, the stakes are as high as they get. His take: skeptics aren't obstacles, they're essential. They show you where AI can go wrong so you can build in the right protections, like agents that evaluate and judge the work of other agents.
On the latest Marketing In The Now, Dilbir and host David Reske explain why AI reliability shouldn't be a debate. It's an engineering problem, and one you can solve. David also shares how Nowspeed worked through the same pushback while rolling out its SEO, GEO, and content strategy agents.
Listen to the full episode 👉 https://f.mtr.cool/f9hb0cai1k